Amphastar Pharmaceuticals, Inc. (AMPH)
22.96
+0.43
(+1.91%)
USD |
NASDAQ |
Sep 01, 16:00
22.98
+0.02
(+0.09%)
After-Hours: 20:00
Amphastar Pharmaceuticals Net Income (TTM) : 78.55M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 78.55M |
| March 31, 2026 | 79.23M |
| December 31, 2025 | 98.09M |
| September 30, 2025 | 111.63M |
| June 30, 2025 | 134.71M |
| March 31, 2025 | 141.63M |
| December 31, 2024 | 159.52M |
| September 30, 2024 | 157.72M |
| June 30, 2024 | 166.52M |
| March 31, 2024 | 154.69M |
| December 31, 2023 | 137.54M |
| September 30, 2023 | 135.29M |
| June 30, 2023 | 101.94M |
| March 31, 2023 | 93.16M |
| December 31, 2022 | 91.39M |
| September 30, 2022 | 77.23M |
| June 30, 2022 | 92.32M |
| March 31, 2022 | 83.60M |
| December 31, 2021 | 63.30M |
| September 30, 2021 | 37.75M |
| June 30, 2021 | 11.58M |
| March 31, 2021 | 1.531M |
| December 31, 2020 | 1.097M |
| September 30, 2020 | 7.644M |
| June 30, 2020 | 3.835M |
| Date | Value |
|---|---|
| March 31, 2020 | 52.18M |
| December 31, 2019 | 46.50M |
| September 30, 2019 | 47.47M |
| June 30, 2019 | 48.10M |
| March 31, 2019 | -1.673M |
| December 31, 2018 | -6.66M |
| September 30, 2018 | -7.591M |
| June 30, 2018 | -9.032M |
| March 31, 2018 | -4.207M |
| December 31, 2017 | 3.827M |
| September 30, 2017 | 0.298M |
| June 30, 2017 | 4.013M |
| March 31, 2017 | 8.936M |
| December 31, 2016 | 10.53M |
| September 30, 2016 | 20.81M |
| June 30, 2016 | 13.91M |
| March 31, 2016 | 0.367M |
| December 31, 2015 | -2.787M |
| September 30, 2015 | -12.84M |
| June 30, 2015 | -15.21M |
| March 31, 2015 | -9.745M |
| December 31, 2014 | -10.70M |
| September 30, 2014 | -6.349M |
| June 30, 2014 | -1.13M |
| March 31, 2014 | 7.86M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Viatris, Inc. | -410.70M |
| Supernus Pharmaceuticals, Inc. | -109.89M |
| Liquidia Corp. | 138.61M |
| ANI Pharmaceuticals, Inc. | 99.95M |
| Corcept Therapeutics, Inc. | 54.20M |